Table 1.
Condition | Predominant gene(s)* |
---|---|
Long QT syndrome | KCNQ1, KCNH2, SCN5A |
Catecholaminergic polymorphic ventricular tachycardia | RYR2, CASQ |
Brugada syndrome | SCN5A |
Cardiac conduction system disease | SCN5A |
Short QT syndrome | KCNH2, KCNQ1, KCNJ2 |
Hypertrophic cardiomyopathy | MYBPC3, MYH7, TNNI3, TNNT2, TPM1 |
Arrhythmogenic ventricular cardiomyopathy | DSC2, DSG2, DSP, JUP, PKP2, TMEM43 |
Dilated cardiomyopathy (with conduction system disease) | TTN, (LMNA, SCN5A) |
Left ventricular noncompaction cardiomyopathy | LBD3 |
Restrictive cardiomyopathy | MYH7, TNNI3 |
Sudden unexplained death & sudden infant death syndrome | KCNQ1, KCNH2, SCN5A, RYR2 |
Atrial fibrillation | Predominant forms are polygenic |
The reader is referred to other sources for comprehensive reviews on the genetic bases of these conditions. 1-8